Pittala, S.; Levy, I.; De, S.; Pandey, S.K.; Melnikov, N.; Hyman, T.; Shoshan-Barmatz, V.
Correction: Pittala et al. The VDAC1-based R-Tf-D-LP4 Peptide as a Potential Treatment for Diabetes Mellitus. Cells 2020, 9, 481. Cells 2024, 13, 1630.
https://doi.org/10.3390/cells13191630
AMA Style
Pittala S, Levy I, De S, Pandey SK, Melnikov N, Hyman T, Shoshan-Barmatz V.
Correction: Pittala et al. The VDAC1-based R-Tf-D-LP4 Peptide as a Potential Treatment for Diabetes Mellitus. Cells 2020, 9, 481. Cells. 2024; 13(19):1630.
https://doi.org/10.3390/cells13191630
Chicago/Turabian Style
Pittala, Srinivas, Idan Levy, Soumasree De, Swaroop Kumar Pandey, Nataly Melnikov, Tehila Hyman, and Varda Shoshan-Barmatz.
2024. "Correction: Pittala et al. The VDAC1-based R-Tf-D-LP4 Peptide as a Potential Treatment for Diabetes Mellitus. Cells 2020, 9, 481" Cells 13, no. 19: 1630.
https://doi.org/10.3390/cells13191630
APA Style
Pittala, S., Levy, I., De, S., Pandey, S. K., Melnikov, N., Hyman, T., & Shoshan-Barmatz, V.
(2024). Correction: Pittala et al. The VDAC1-based R-Tf-D-LP4 Peptide as a Potential Treatment for Diabetes Mellitus. Cells 2020, 9, 481. Cells, 13(19), 1630.
https://doi.org/10.3390/cells13191630
